A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma.
Expert Rev Anticancer Ther
; 23(2): 199-206, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36723678
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biological Products
/
Lymphoma, Follicular
/
Lymphoma, Large B-Cell, Diffuse
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Expert Rev Anticancer Ther
Journal subject:
NEOPLASIAS
/
TERAPEUTICA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: